U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
177871177871Training Intensity After Coronary Bypass GraftingTerminatedNo Results AvailableCoronary Artery BypassBehavioral: Exercise training|Behavioral: Exercise traininghttps://ClinicalTrials.gov/show/NCT00226733
177872177872Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT StudyCompletedNo Results AvailableAlcoholism|Alcohol DependenceProcedure: Outpatient detoxification programhttps://ClinicalTrials.gov/show/NCT00226720
177873177873Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand DermatitisCompletedNo Results AvailableChronic Hand DermatitisDrug: Pimecrolimus Cream 1%https://ClinicalTrials.gov/show/NCT00226707
177874177874Alcohol and Gender Effects on Stress Circuit FunctionCompletedNo Results AvailableAlcoholism|Stress|Alcohol DependenceDrug: Citalopram|Other: Placebohttps://ClinicalTrials.gov/show/NCT00226694
177875177875Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD)CompletedNo Results AvailableSudden Cardiac ArrestBehavioral: Nursing Telephone Support Protocol|Behavioral: Usual Carehttps://ClinicalTrials.gov/show/NCT00226681
177876177876XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain EdemaWithdrawnNo Results AvailableBrain Edema|Brain TumorDrug: hCRF|Drug: placebo hCRFhttps://ClinicalTrials.gov/show/NCT00226668
177877177877An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated StudiesCompletedHas ResultsBrain Edema|Brain TumorDrug: hCRF [XERECEPT (corticorelin acetate injection)]https://ClinicalTrials.gov/show/NCT00226655
177878177878Treatment of Mild and Subthreshold Depressive DisordersActive, not recruitingNo Results AvailableDepressionDrug: Sertralin|Behavioral: Cognitive-behavioral therapy|Drug: Placebo|Behavioral: Non-specific supporting group therapyhttps://ClinicalTrials.gov/show/NCT00226642
177879177879Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSCCompletedNo Results AvailableAbdominal Aortic AneurysmProcedure: Endovascular vs Open Repairhttps://ClinicalTrials.gov/show/NCT00226629
177880177880Zinc Supplementation in Cholera PatientsCompletedNo Results AvailableCholeraDrug: Zinchttps://ClinicalTrials.gov/show/NCT00226616
177881177881Lyske Trial (Danish) Groin TrialActive, not recruitingNo Results AvailableGroin Injuries in Football PlayersBehavioral: Specific training programme (behavior)https://ClinicalTrials.gov/show/NCT00226603
177882177882Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLCCompletedHas ResultsLung CancerDrug: Gemcitabine|Drug: Carboplatin|Drug: Paclitaxel|Procedure: Radiationhttps://ClinicalTrials.gov/show/NCT00226590
177883177883Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.CompletedHas ResultsLung CancerDrug: Gemcitabine|Drug: Pemetrexed|Procedure: Surgeryhttps://ClinicalTrials.gov/show/NCT00226577
177884177884Genetic Determinants of Opioids AnalgesiaCompletedNo Results AvailableNephrolithiasisDrug: Alfentanilhttps://ClinicalTrials.gov/show/NCT00226564
177885177885Vascular Response to Isoproterenol and β2 Adrenergic Receptor PolymorphismsCompletedNo Results AvailableCoronary DiseaseDrug: Isoproterenolhttps://ClinicalTrials.gov/show/NCT00226551
177886177886Prediction of Drug Interactions With CYP2C9 SubstratesCompletedNo Results AvailableHealthy VolunteersDrug: Phenytoin|Drug: Rifampicin|Drug: Diclophenac|Drug: Fluconazolehttps://ClinicalTrials.gov/show/NCT00226538
177887177887Effect of Metal Skin Sensitivity on Restenosis After Stent ImplantationActive, not recruitingNo Results AvailableCoronary Stent RestenosisProcedure: skin sensitivity testhttps://ClinicalTrials.gov/show/NCT00226525
177888177888To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity ConditioningWithdrawnNo Results AvailableAcute Myeloid Leukemia|Myelodysplastic SyndromeDrug: Campath-1H /ATGhttps://ClinicalTrials.gov/show/NCT00226512
177889177889Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNo Results AvailableVaricellaBiological: Priorix-tetraâ„¢|Biological: Priorixâ„¢|Biological: Varilrixâ„¢https://ClinicalTrials.gov/show/NCT00226499
177890177890Examination and Treatment of Elderly After a FallCompletedNo Results AvailableAccidental FallsOther: multifactorial intervention|Other: Usual carehttps://ClinicalTrials.gov/show/NCT00226486
177891177891Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant MelanomaRecruitingNo Results AvailableMetastatic MelanomaDrug: Cisplatin, Vindesine, Dacarbazine (drugs)https://ClinicalTrials.gov/show/NCT00226473
177892177892Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.CompletedNo Results AvailableParkinson's DiseaseDrug: Fetal porcine cells, Neurocell-PDhttps://ClinicalTrials.gov/show/NCT00226460
177893177893Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNo Results AvailableChronic Hepatitis BDrug: Pegylated Interferon|Drug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00226447
177894177894Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)CompletedNo Results AvailableHIV Infection|TuberculosisProcedure: Early antiretroviral treatment|Procedure: Late antiretroviral treatmenthttps://ClinicalTrials.gov/show/NCT00226434
177895177895Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant PainCompletedNo Results AvailableChronic PainDrug: Oxymorphone Extended Releasehttps://ClinicalTrials.gov/show/NCT00226421
177896177896Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha InterferonRecruitingNo Results AvailableAdjuvant|Stage III Malignant Melanoma|Interferon Alpha|TherapyDrug: Interferon-alpha-2bhttps://ClinicalTrials.gov/show/NCT00226408
177897177897Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute PainCompletedNo Results AvailableAcute PainDrug: Oxymorphone immediate releasehttps://ClinicalTrials.gov/show/NCT00226395
177898177898Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNo Results AvailableChronic Hepatitis BDrug: Pegylated Interferon-alfa-2ahttps://ClinicalTrials.gov/show/NCT00226382
177899177899Cylexin for Reduction of Reperfusion Injury in Infant Heart SurgeryCompletedNo Results AvailableCongenital Heart DefectsDrug: CY-1503https://ClinicalTrials.gov/show/NCT00226369
177900177900Natural Supplements for Unipolar DepressionRecruitingNo Results AvailableUnipolar DepressionDrug: Supplements of L-methionine, betaine and folatehttps://ClinicalTrials.gov/show/NCT00226356

* Görseller ve İçerik tekif hakkına sahip olabilir